<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04651010</url>
  </required_header>
  <id_info>
    <org_study_id>PIMISUTT</org_study_id>
    <secondary_id>2020-A021118-31</secondary_id>
    <nct_id>NCT04651010</nct_id>
  </id_info>
  <brief_title>Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)</brief_title>
  <acronym>PIMISUTT</acronym>
  <official_title>Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study aims to measure metabolic and functional parameters of the infarcted territory by&#xD;
      multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the&#xD;
      middle cerebral artery and treated by thrombectomy in order to correlate those parameters to&#xD;
      clinical outcome (evaluated by modified Rankin score) at 3 months.&#xD;
&#xD;
      We aim to find early radiologic predictive factors for favorable clinical outcome in this&#xD;
      population of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment of acute ischemic stroke in the setting of intracranial large artery occlusion&#xD;
      and especially middle cerebral artery occlusion (MCAO) with intravenous tissue plasminogen&#xD;
      activator (IV-tPA) is associated with low rates of recanalization and high rates of&#xD;
      neurological morbidity and functional dependence.&#xD;
&#xD;
      In the last few years, endovascular intervention (mechanical thrombectomy) has proven its&#xD;
      safety and its efficacy on clinical outcome in patients diagnosed with MCAO and is now&#xD;
      commonly recommended.&#xD;
&#xD;
      However, in this population of patients treated by thrombectomy, very few predictive factors,&#xD;
      except for the post-procedural recanalization score (TICI), do exist to foresee the&#xD;
      variability of clinical outcome.&#xD;
&#xD;
      Tissue viability of the infarcted territory can be approached by the measure of metabolic and&#xD;
      morphological parameters (Na+, H+, phosphore, diffusion imaging) which can be non-invasively&#xD;
      done by multimodal MRI, as suggest by recently published studies.&#xD;
&#xD;
      Our study plans to measure these parameters between 12 and 24 hours after acute ischemic&#xD;
      stroke in patients with MCAO treated by thrombectomy in order to correlate those parameters&#xD;
      to clinical outcome at 3 months (modifier Rankin Score).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between modified Rankin score at 3 months and multimodal MRI data</measure>
    <time_frame>Month 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge National Institute of Health Stroke Score (NIHSS)</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institute of Health Stroke (NIHSS) score at 3 months</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NIHSS score at 3 months compared to post-thrombectomy</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Middle Cerebral Artery Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Multimodal MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multimodal MRI</intervention_name>
    <description>Multimodal MRI will be realized between 12 and 24 hours after thrombectomy</description>
    <arm_group_label>Multimodal MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged ≥ 18 years old&#xD;
&#xD;
          -  Hospitalized at the Poitiers University Hospital&#xD;
&#xD;
          -  Acute middle cerebral artery occlusion diagnosed by CT-scan or MRI&#xD;
&#xD;
          -  NIHSS score ≥ 6 at admission&#xD;
&#xD;
          -  Treated by thrombectomy with or without fibrinolysis&#xD;
&#xD;
          -  Written information delivered to the patient or his relatives concerning the study and&#xD;
             its benefit and risk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients or relatives whom a loyal information about the study cannot be given&#xD;
&#xD;
          -  Patient with cognitive impairments before MRI.&#xD;
&#xD;
          -  Patients who cannot undergo MRI because of contraindications&#xD;
&#xD;
          -  Patients too deteriorated to tolerate one hour long exam&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guillaume HERPE, Dr</last_name>
    <phone>05 49 44 33 89</phone>
    <email>guillaume.herpe@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Céline DELETAGE</last_name>
    <phone>05 49 44 38 54</phone>
    <phone_ext>+33</phone_ext>
    <email>celine.deletage@chu-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume HERPE, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>March 25, 2021</last_update_submitted>
  <last_update_submitted_qc>March 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic stroke</keyword>
  <keyword>acute middle cerebral artery occlusion</keyword>
  <keyword>multimodal MRI</keyword>
  <keyword>thrombectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

